Omnicell Inc logo

OMCL

Omnicell Inc

$52.05

Earnings Summary

Revenue
$228.81Mn
Net Profits
$19.98Mn
Net Profit Margins
8.73%

Highlights

Revenue:

Omnicell Inc’s revenue jumped 12.01% since last year same period to $228.81Mn in the Q3 2019. On a quarterly growth basis, Omnicell Inc has generated 5.24% jump in its revenue since last 3-months.

Net Profits:

Omnicell Inc’s net profit jumped 46.63% since last year same period to $19.98Mn in the Q3 2019. On a quarterly growth basis, Omnicell Inc has generated 25.08% jump in its net profits since last 3-months.

Net Profit Margins:

Omnicell Inc’s net profit margin jumped 30.91% since last year same period to 8.73% in the Q3 2019. On a quarterly growth basis, Omnicell Inc has generated 18.85% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Omnicell Inc post its latest quarter earnings

EPS Estimate Current Quarter
1.21
EPS Estimate Current Year
1.21

Highlights

EPS Estimate Current Quarter:

Omnicell Inc’s earning per share (EPS) estimates for the current quarter stand at 1.21 - a 26.78% jump from last quarter’s estimates.

EPS Estimate Current Year:

Omnicell Inc’s earning per share (EPS) estimates for the current year stand at 1.21.

Key Ratios

Key ratios of the Omnicell Inc post its Q2 2022 earnings

Earning Per Share (EPS)
0.84
Return on Assets (ROA)
0.02
Return on Equity (ROE)
0.04

Highlights

Earning Per Share (EPS):

Omnicell Inc’s earning per share (EPS) fell -13.4% since last year same period to 0.84 in the Q2 2022. This indicates that the Omnicell Inc has generated -13.4% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Omnicell Inc’s return on assets (ROA) stands at 0.02.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Omnicell Inc’s return on equity (ROE) stands at 0.04.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-08-09
0.85
0.84
-1.18%
2022-05-09
0.69
0.83
21.17%

Company Information

Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 7,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

Organisation
Omnicell Inc
Headquarters
590 East Middlefield Road, Mountain View, CA, United States, 94043
Employees
4160
Industry
Technology Services
CEO
Randall Lipps

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*